New York, NY (PRWEB) March 11, 2015
A world-renowned physician-scientist in cardiovascular medicine and imaging, Dr. Narula will lead comprehensive cardiac services at Mount Sinai St. Luke’s and Mount Sinai Roosevelt hospital campuses of the Mount Sinai Health System.
“It is a very exciting milestone in my career to be joining the talented team of cardiologists and cardiovascular surgeons at Mount Sinai St. Luke’s and Mount Sinai Roosevelt,” says Dr. Jagat Narula, the new Chief of Cardiology at Mount Sinai Roosevelt and Mount Sinai St. Luke’s. “Together we will increase our community’s access to healthcare while offering the most advanced cardiovascular care, research, and clinical trials for patients on the West Side of Manhattan.”
Dr. Narula will also continue to serve as Director of Cardiovascular Imaging for the Mount Sinai Health System, Professor of Medicine (Cardiology) and Radiology, and Associate Dean for Global Affairs at Icahn School of Medicine at Mount Sinai.
“We welcome Dr. Jagat Narula and his leading expertise in cardiology and cardiac imaging to Mount Sinai St. Luke’s,” says Arthur Gianelli, President of Mount Sinai St. Luke’s. “With Dr. Narula on our team, we will take our cardiac patient care, research, and imaging capabilities to new heights.”
“Congratulations to Dr. Narula on his new appointment to our Mount Sinai Roosevelt team,” says Evan Flatow, MD, President of Mount Sinai Roosevelt. “Under his strong leadership, cardiovascular services of Mount Sinai St. Luke’s and Mount Sinai Roosevelt will become one of the premier destinations for heart care.”
The former Chief of Cardiology at Mount Sinai St. Luke’s and Mount Sinai Roosevelt, Alan Rozanski, MD, will now serve as Director of Wellness and Prevention Programs for Mount Sinai Heart at the Mount Sinai Health System for the creation of future prevention and wellness programs across all campuses.
“We thank Dr. Narula for his dedicated and pioneering work at Mount Sinai Heart since 2011 at The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai,” says Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital. “He is a true innovator and I look forward to our future collaborations to further advance cardiac patient care, research, and medical education across the Mount Sinai Health System and beyond.”
As a world-renowned translational researcher in cardiovascular medicine and imaging, Dr. Narula is widely recognized for his contributions toward preventing and understanding heart attacks and heart failure. Pioneering work from Dr. Narula has included the description of the phenomenon of heart muscle cell suicide, and the detection of atherosclerotic plaques that are likely to cause acute heart attacks. His research combines molecular and subcellular pathology and imaging with clinical imaging of the failing heart muscle cells and high-risk atherosclerotic plaques to develop strategies for prevention of cardiovascular disease in developed as well as developing countries. He is also involved in population-based heart attack prevention programs, including the Heart Attack Prevention Program for You (HAPPY). In addition, he helped incorporate handheld ultrasound technology into the medical education curriculum at Icahn School of Medicine at Mount Sinai.
The American College of Cardiology has named Dr. Narula a Master of the American College of Cardiology (MACC), one of the "Innovators of CV Medicine", and awarded him its Gifted Educator Award. He will also be receiving the Distinguished Scientist Award at the American College of Cardiology’s annual scientific meeting in San Diego on March 16, 2015. With more than 1,000 original research publications or presentations to his credit and more than 30 books or journal supplements edited, Dr. Narula serves as the Editor-in-Chief of the Journal of American College of Cardiology-CV Imaging and Global Heart, the journal of the World Heart Federation. His research has been funded in part by grants from the National Institutes of Health (NIH).
After completing his cardiology fellowship training and PhD in Cardiovascular Immunology from the All India Institute of Medical Sciences in Delhi, India, Dr. Narula began work at Massachusetts General Hospital and Harvard Medical School in 1989. There, he completed cardiology, heart failure and transplantation, and nuclear cardiology fellowships, and joined the cardiology faculty. In 1997, he moved to the Hahnemann University School of Medicine, Philadelphia. He was Thomas J. Vischer Professor of Medicine, Chief of the Division of Cardiology, Vice-Chairman of the Department of Internal Medicine, and Director of Heart Failure and Transplantation Center at Hahnemann, when he relocated to the University of California (Irvine) School of Medicine in 2003. At the UC Irvine, he served as the Chief of the Division of Cardiology, Associate Dean for Research, and Director of the Cardiovascular Center of the UC Irvine's Douglas Hospital, before joining Mount Sinai in April 2011.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community based facilities to tertiary and quaternary care.
The System includes approximately 6,600 primary and specialty care physicians, 12minority owned free standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.
For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube